China Medical Technologies
Encyclopedia
China Medical Technologies, Inc. (NASDAQ
NASDAQ
The NASDAQ Stock Market, also known as the NASDAQ, is an American stock exchange. "NASDAQ" originally stood for "National Association of Securities Dealers Automated Quotations". It is the second-largest stock exchange by market capitalization in the world, after the New York Stock Exchange. As of...

:CMED) is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders.

Business

The ECLIA business, which consists of ECLIA analyzer and reagent kits, is an IVD system based on ECLIA technology. The reagent kits are used to detect various thyroid disorders, diabetes, hepatitis, Down syndrome, liver fibrosis, disorders related to reproduction and growth and various types of tumors.

The FISH business, which consists of FISH imaging analyzer and FISH probes, is a molecular diagnostic system based on FISH technology. FISH probes are molecular diagnostic reagents used with FISH imaging analyzer for the prenatal and postnatal diagnosis of various genetic diseases and for the early detection and prognosis of various cancers.

THE SPR business, which consists of SPR system and HPV-DNA chips, is a molecular diagnostic system based on SPR technology. The HPV-DNA chips are label-free DNA chips for the diagnosis of HPV infection and genotyping of HPV.

External links

The source of this article is wikipedia, the free encyclopedia.  The text of this article is licensed under the GFDL.
 
x
OK